NASDAQ:BTAI | Key Financial Ratios | BioXcel Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-300.21-0.9-246.05%61.37%
2026-03-310.62-0.95-221.41%71.38%
2025-12-310.83-1.15-155.62%73.22%
2025-09-301.17-1.23-152.28%76.71%
2025-06-300.76-1.01-197.56%47.32%
2025-03-311.48-1.17-103.88%44.43%
2024-12-311.68-1.1-155.46%64.02%
2024-09-301.87-145.21%82.91%
2024-06-302.35-164.79%145.13%
2024-03-312.57-185.91%211.50%
2023-12-312.65-242.94%316.86%
2023-09-302.51-210.66%521.09%
2023-06-303.98-144.85%-3460.50%
2023-03-316.16-103.87%-352.95%
2022-12-316.17-80.52%-215.90%
2022-09-3010.34-55.99%-107.94%
2022-06-3012.25-49.18%-74.32%
2022-03-3112.98-53.08%-57.74%
2021-12-3114.21-44.66%-48.24%
2021-09-3017.6-38.99%-41.49%
2021-06-3022.24-35.51%-37.33%
2021-03-3115.97-46.73%-50.14%
2020-12-3118.33-37.36%-39.75%
2020-09-3014.45-29.05%-31.39%
2020-06-304.23-76.10%-100.43%
2020-03-316.82-47.40%-56.04%
2019-12-314.03-90.59%-122.58%
2019-09-305.04-72.70%-92.30%
2019-06-303.93-80.63%-109.86%
2019-03-315.59-55.03%-68.56%
2018-12-319.26-44.25%-49.55%
2018-09-3023.32-30.76%-32.13%
2018-06-3036.78-21.00%-21.58%
2018-03-3113.36-14.72%-15.91%
2017-12-310.38-334.98%462.22%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-310.83-1.15-155.62%73.22%
2024-12-311.68-1.1-155.46%64.02%
2023-12-312.65-242.94%316.86%
2022-12-316.17-80.52%-215.90%
2021-12-3114.21-44.66%-48.24%
2020-12-3118.33-37.36%-39.75%
2019-12-314.03-90.59%-122.58%
2018-12-319.26-44.25%-49.55%
2017-12-310.38-334.98%462.22%